The role of galectin and CXC chemokine receptor in tumor progression of renal cell carcinoma
博士 === 國立陽明大學 === 醫學生物技術暨檢驗學系 === 102 === Renal cell carcinoma (RCC) is the most common kidney cancer noted in adult population. More than one-third of patients will present with locally advanced or metastatic disease at the time of diagnosis. Although targeted therapy has been the standard of care...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | en_US |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/87459142018794245376 |